Paul Lee Selected Research

stannous mesoporphyrin

5/2013	The heme oxygenase system selectively enhances the anti-inflammatory macrophage-M2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats.
1/2013	The risk of heart failure and cardiometabolic complications in obesity may be masked by an apparent healthy status of normal blood glucose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Lee Research Topics

Disease

9	Neoplasms (Cancer) 04/2022 - 02/2004
8	Inflammation (Inflammations) 02/2016 - 06/2004
8	Obesity 02/2016 - 01/2009
7	Critical Illness (Critically Ill) 01/2016 - 12/2009
5	Vitamin D Deficiency 11/2015 - 01/2009
4	Insulin Resistance 01/2015 - 01/2013
4	Myocardial Infarction 09/2008 - 01/2004
3	Weight Gain 05/2016 - 01/2009
3	Atherosclerotic Plaque (Atheroma) 06/2007 - 03/2003
3	Atherosclerosis 06/2007 - 03/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2022 - 09/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 01/2016
2	Dyslipidemias (Dyslipidemia) 01/2015 - 11/2013
2	Retinal Vein Occlusion 07/2013 - 10/2012
2	Macular Edema 07/2013 - 10/2012
2	Hypertrophy 05/2013 - 01/2013
2	Cardiomegaly (Heart Hypertrophy) 05/2013 - 01/2013
2	Heart Failure 01/2013 - 01/2004
2	Thrombosis (Thrombus) 10/2012 - 06/2005
2	Stroke (Strokes) 02/2012 - 02/2009
2	Anaphylaxis (Anaphylactic Shock) 07/2011 - 11/2007
2	Hemorrhage 03/2011 - 09/2008
2	Body Weight (Weight, Body) 10/2010 - 06/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2008 - 09/2003
2	Hypercholesterolemia 06/2007 - 03/2003
1	Disease Progression 04/2022
1	Intervertebral Disc Degeneration 04/2022
1	Aneurysm (Aneurysms) 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	COVID-19 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Knee Osteoarthritis 10/2019
1	Eosinophilia 01/2019
1	Uniparental Disomy 01/2019
1	Tracheobronchomalacia 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018

Drug/Important Bio-Agent (IBA)

9	Vitamin D FDA LinkGeneric 08/2013 - 04/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2009
4	Interleukin-6 (Interleukin 6)IBA 11/2015 - 06/2004
4	AntioxidantsIBA 12/2014 - 03/2003
4	CytokinesIBA 05/2013 - 02/2004
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2016
3	EnzymesIBA 01/2017 - 09/2008
3	LipidsIBA 01/2015 - 09/2003
3	Ranibizumab (Lucentis)FDA Link 07/2013 - 10/2012
3	Insulin (Novolin)FDA Link 05/2013 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2016
2	Parathyroid Hormone (Parathormone)IBA 11/2015 - 02/2013
2	Cholecalciferol (Vitamin D3)FDA Link 11/2015 - 11/2009
2	Triglycerides (Triacylglycerol)IBA 12/2014 - 09/2003
2	Hormones (Hormone)IBA 08/2013 - 08/2002
2	tetrachloroisophthalonitrile (Bravo)IBA 07/2013 - 10/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 06/2004
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 05/2013 - 01/2013
2	stannous mesoporphyrinIBA 05/2013 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 01/2013
2	Hemin (Panhematin)FDA Link 05/2013 - 01/2013
2	PolymersIBA 04/2011 - 03/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2009 - 02/2009
2	CholesterolIBA 06/2007 - 09/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2007 - 09/2003
2	Malondialdehyde (Propanedial)IBA 09/2003 - 03/2003
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	NucleotidesIBA 04/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	osimertinibIBA 01/2021
1	Syntex adjuvant formulationIBA 12/2020
1	ruxolitinibIBA 12/2020
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020
1	InterferonsIBA 12/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Clofarabine (Clolar)FDA Link 01/2020
1	GermaniumIBA 10/2019
1	PotassiumIBA 01/2019
1	tributyl phosphate (TBP)IBA 01/2019
1	SodiumIBA 01/2019
1	HydrogelsIBA 01/2019
1	ChloridesIBA 01/2019
1	Estrogen ReceptorsIBA 01/2018
1	EpitopesIBA 01/2018

Therapy/Procedure

15	Therapeutics 04/2022 - 01/2004
3	Percutaneous Coronary Intervention 03/2012 - 09/2002
2	Drug Therapy (Chemotherapy) 01/2019 - 04/2013
2	Length of Stay 01/2018 - 01/2017
2	Stents 10/2012 - 06/2005
1	Diskectomy (Discectomy) 04/2022
1	Immunotherapy 09/2021
1	Molecular Targeted Therapy 09/2021
1	Surgical Instruments (Clip) 01/2021
1	Adjuvant Radiotherapy 01/2021
1	Ligation 01/2021
1	Patient Readmission 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2020